Citigroup Lowers PT on Catalyst Health Solutions to $63

Symbols: CHSI
Tags: Citigroup
Share

Citigroup has lowered the price target on Catalyst Health Solutions (NASDAQ: CHSI) from $74 to $63 and maintains its Buy rating.


 
 
< Previous
JP Morgan Raises PT on Mako Surgical to $37
Next >
Piper Jaffray Upgrades DynaVox to Overweight, PT Lowered to $5
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust